BCL2 and glioblastoma: Thus, the reduction of Bcl2 and NUMB decreases AKT phosphorylation and increases the apoptotic response in glioblastoma cell lines, highlighting the importance of ZIKV as a potential oncolytic therapy for glioblastoma treatment [11].